Literature DB >> 36109648

Development of selective inhibitors of phosphatidylinositol 3-kinase C2α.

Wen-Ting Lo1, Hassane Belabed1, Murat Kücükdisli1, Juliane Metag1, Yvette Roske2, Polina Prokofeva3, Yohei Ohashi4, André Horatscheck1, Davide Cirillo1, Michael Krauss1, Christopher Schmied1, Martin Neuenschwander1, Jens Peter von Kries1, Guillaume Médard3, Bernhard Kuster3, Olga Perisic4, Roger L Williams4, Oliver Daumke2, Bernard Payrastre5,6, Sonia Severin5, Marc Nazaré7, Volker Haucke8,9.   

Abstract

Phosphatidylinositol 3-kinase type 2α (PI3KC2α) and related class II PI3K isoforms are of increasing biomedical interest because of their crucial roles in endocytic membrane dynamics, cell division and signaling, angiogenesis, and platelet morphology and function. Herein we report the development and characterization of PhosphatidylInositol Three-kinase Class twO INhibitors (PITCOINs), potent and highly selective small-molecule inhibitors of PI3KC2α catalytic activity. PITCOIN compounds exhibit strong selectivity toward PI3KC2α due to their unique mode of interaction with the ATP-binding site of the enzyme. We demonstrate that acute inhibition of PI3KC2α-mediated synthesis of phosphatidylinositol 3-phosphates by PITCOINs impairs endocytic membrane dynamics and membrane remodeling during platelet-dependent thrombus formation. PITCOINs are potent and selective cell-permeable inhibitors of PI3KC2α function with potential biomedical applications ranging from thrombosis to diabetes and cancer.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36109648     DOI: 10.1038/s41589-022-01118-z

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   16.174


  50 in total

Review 1.  Signalling through the lipid products of phosphoinositide-3-OH kinase.

Authors:  A Toker; L C Cantley
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

2.  A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.

Authors:  Baptiste Ronan; Odile Flamand; Lionel Vescovi; Christine Dureuil; Laurence Durand; Florence Fassy; Marie-France Bachelot; Annabelle Lamberton; Magali Mathieu; Thomas Bertrand; Jean-Pierre Marquette; Youssef El-Ahmad; Bruno Filoche-Romme; Laurent Schio; Carlos Garcia-Echeverria; Hélène Goulaouic; Benoit Pasquier
Journal:  Nat Chem Biol       Date:  2014-10-19       Impact factor: 15.040

Review 3.  Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human Disease.

Authors:  John E Burke
Journal:  Mol Cell       Date:  2018-09-06       Impact factor: 17.970

Review 4.  Class II PI3K Functions in Cell Biology and Disease.

Authors:  Federico Gulluni; Maria Chiara De Santis; Jean Piero Margaria; Miriam Martini; Emilio Hirsch
Journal:  Trends Cell Biol       Date:  2019-01-25       Impact factor: 20.808

5.  Structural insights into phosphoinositide 3-kinase catalysis and signalling.

Authors:  E H Walker; O Perisic; C Ried; L Stephens; R L Williams
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

6.  Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma.

Authors:  M E Pacold; S Suire; O Perisic; S Lara-Gonzalez; C T Davis; E H Walker; P T Hawkins; L Stephens; J F Eccleston; R L Williams
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

Review 7.  The expanding spectrum of neurological disorders of phosphoinositide metabolism.

Authors:  Jonathan R Volpatti; Almundher Al-Maawali; Lindsay Smith; Aqeela Al-Hashim; Julie A Brill; James J Dowling
Journal:  Dis Model Mech       Date:  2019-08-13       Impact factor: 5.758

Review 8.  PI3K isoforms in cell signalling and vesicle trafficking.

Authors:  Benoit Bilanges; York Posor; Bart Vanhaesebroeck
Journal:  Nat Rev Mol Cell Biol       Date:  2019-09       Impact factor: 94.444

Review 9.  Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases.

Authors:  Jocelyn Laporte; Florence Bedez; Alessandra Bolino; Jean-Louis Mandel
Journal:  Hum Mol Genet       Date:  2003-08-12       Impact factor: 6.150

10.  Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.

Authors:  Ruzica Bago; Nazma Malik; Michael J Munson; Alan R Prescott; Paul Davies; Eeva Sommer; Natalia Shpiro; Richard Ward; Darren Cross; Ian G Ganley; Dario R Alessi
Journal:  Biochem J       Date:  2014-11-01       Impact factor: 3.857

View more
  1 in total

1.  Antagonistic control of active surface integrins by myotubularin and phosphatidylinositol 3-kinase C2β in a myotubular myopathy model.

Authors:  Paula Samsó; Philipp A Koch; York Posor; Wen-Ting Lo; Hassane Belabed; Marc Nazare; Jocelyn Laporte; Volker Haucke
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.